BerandaIMRSQ • OTCMKTS
add
IMRIS Ord Shs
Tutup sebelumnya
$0,00
Volume Rata-Rata
372,00
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | 2014info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 28,89 jt | — |
Biaya operasional | 33,07 jt | — |
Laba bersih | -30,39 jt | — |
Margin laba bersih | -105,18 | — |
Penghasilan per saham | -0,58 | 30,12% |
EBITDA | -20,30 jt | — |
Tarif pajak efektif | -0,80% | — |
Neraca
Total aset
Total liabilitas
| (USD) | 2014info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 5,00 jt | — |
Total aset | 65,48 jt | — |
Total liabilitas | 53,69 jt | — |
Total ekuitas | 11,79 jt | — |
Saham yang beredar | 62,59 jt | — |
Harga terhadap nilai buku | 0,00 | — |
Tingkat pengembalian aset | -19,15% | — |
Tingkat pengembalian modal | -31,61% | — |
Arus Kas
Perubahan kas bersih
| (USD) | 2014info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -30,39 jt | — |
Kas dari operasi | -10,91 jt | — |
Kas dari investasi | 4,49 jt | — |
Kas dari pembiayaan | 3,50 jt | — |
Perubahan kas bersih | -1,38 jt | — |
Arus kas bebas | 4,58 jt | — |
Tentang
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.
The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Didirikan
2005
Kantor pusat
Situs
Karyawan
121
